Article Details
Retrieved on: 2022-10-12 06:53:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company said this amount is equivalent to almost 30% of the global contract manufacturing capacity for biopharma firms. With this volume, Samsung ...
Article found on: www.econotimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here